MedTrace Logo

Intention to Prescribe/Take OAC Depending on the Number of Risk Diagrams , and Period for the Estimation of the Risk.

NCT02746107 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 968

Last updated 2016-10-31

Study results available
· View outcomes & findings →

Summary

Randomized study concerning the effect of the number of risk diagrams (with treatment +/- without treatment), the period of stroke risk estimation (one year or five years) and the target of prescription (the patient with atrial fibrillation or the physician himself, imagining she/he has atrial fibrillation) on the intention to prescribe or not oral anticoagulation.

Conditions

Interventions

OTHER

decision aid

decision aid with one/two diagrams decision aid with risk over one/five years decision aid with CHA2DS2-VASC risk score 1 to 5 target of the prescription: patient / physician hinself

Sponsors & Collaborators

  • Cristian Baicus

    lead OTHER

Principal Investigators

  • Cristian Baicus, PhD · Carol Davila University of Medicine and Pharmacy Bucharest - Colentina Hospital

Study Design

Allocation
RANDOMIZED
Masking
NONE
Model
FACTORIAL

Eligibility

Min Age
24 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-03-31
Primary Completion
2016-06-30
Completion
2016-06-30

Countries

  • Romania

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02746107 on ClinicalTrials.gov